Polymorphic Variation in TIRAP Is Not Associated with Susceptibility to Childhood TB but May Determine Susceptibility to TBM in Some Ethnic Groups

Host recognition of mycobacterial surface molecules occurs through toll like receptors (TLR) 2 and 6. The adaptor protein TIRAP mediates down stream signalling of TLR2 and 4, and polymorphisms in the TIRAP gene (TIRAP) have been associated with susceptibility and resistance to tuberculosis (TB) in adults. In order to investigate the role of polymorphic variation in TIRAP in childhood TB in South Africa, which has one of the highest TB incidence rates in the world, we screened the entire open reading frame of TIRAP for sequence variation in two cohorts of childhood TB from different ethnic groups (Xhosa and mixed ancestry). We identified 13 SNPs, including seven previously unreported, in the two cohorts, and found significant differences in frequency of the variants between the two ethnic groups. No differences in frequency between individual SNPs or combinations were found between TB cases and controls in either cohort. However the 558C→T SNP previously associated with TB meningitis (TBM) in a Vietnamese population was found to be associated with TBM in the mixed ancestry group. Polymorphisms in TIRAP do not appear to be involved in childhood TB susceptibility in South Africa, but may play a role in determining occurrence of TBM.

[1]  Smith Mh.  Tuberculosis in children and adolescents. , 1989 .

[2]  M. Crépin,et al.  Efficient mutation detection in MEN1 gene using a combination of single‐strand conformation polymorphism (MDGA™) and heteroduplex analysis , 2003, Electrophoresis.

[3]  J. Basilion,et al.  Single-nucleotide polymorphisms can cause different structural folds of mRNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. Britton,et al.  Life and death in the granuloma: immunopathology of tuberculosis , 2007, Immunology and cell biology.

[5]  M. Fenton,et al.  Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[6]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[7]  L. Zhao,et al.  A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. , 2006, The Journal of infectious diseases.

[8]  E. Julián,et al.  TLR2 but not TLR4 Signalling is Critically Involved in the Inhibition of IFN‐γ‐induced Killing of Mycobacteria by Murine Macrophages , 2007, Scandinavian journal of immunology.

[9]  K. Cummings,et al.  Tuberculosis in children and adolescents: California, 1985 to 1995. , 1998, The Pediatric infectious disease journal.

[10]  Comstock Gw.  Tuberculosis in twins: a re-analysis of the Prophit survey. , 1978, The American review of respiratory disease.

[11]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[13]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[14]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[15]  R. Gie,et al.  Childhood tuberculosis in an urban population in South Africa: burden and risk factor , 1999, Archives of disease in childhood.

[16]  T. Walls,et al.  Global epidemiology of paediatric tuberculosis. , 2004, The Journal of infection.

[17]  K. Miyake.  Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. , 2004, Trends in microbiology.

[18]  R. Modlin,et al.  The role of Toll-like receptors in combating mycobacteria. , 2004, Seminars in immunology.

[19]  R. Döffinger,et al.  In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. , 2000, The Journal of clinical investigation.

[20]  D. Golenbock,et al.  The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. , 1999, Journal of immunology.

[21]  J. Todd,et al.  Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations , 2008, Nature Genetics.

[22]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[23]  L. Hurst,et al.  Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.

[24]  J. Anaya,et al.  TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[25]  E. Schurr,et al.  Genetic Susceptibility to Tuberculosis , 2002, Clinical chemistry and laboratory medicine.

[26]  L. Hurst,et al.  Exonic splicing regulatory elements skew synonymous codon usage near intron-exon boundaries in mammals. , 2007, Molecular biology and evolution.

[27]  K. Shokat,et al.  Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure , 2006, Science.

[28]  George A. De Vos,et al.  Ethnic identity : problems and prospects for the twenty-first century , 2006 .

[29]  S. Dorman,et al.  Interferon-gamma and interleukin-12 pathway defects and human disease. , 2000, Cytokine & growth factor reviews.

[30]  A. Hill,et al.  The immunogenetics of human infectious diseases. , 1998, Annual review of immunology.

[31]  R. Flavell,et al.  The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors , 2002, Nature.

[32]  G. Cooke,et al.  Genetics of susceptibitlity to human infectious disease , 2001, Nature Reviews Genetics.

[33]  S. Dorman,et al.  Interferon-γ and interleukin-12 pathway defects and human disease , 2000 .

[34]  J. Casanova,et al.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.